Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant force » significant source (Expand Search), significant sources (Expand Search), significant concern (Expand Search)
force decrease » fold decrease (Expand Search), forces increased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant force » significant source (Expand Search), significant sources (Expand Search), significant concern (Expand Search)
force decrease » fold decrease (Expand Search), forces increased (Expand Search)
-
2181
-
2182
-
2183
-
2184
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2185
-
2186
-
2187
-
2188
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2189
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2190
-
2191
-
2192
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2193
-
2194
-
2195
-
2196
-
2197
-
2198
-
2199
-
2200
Molecular docking showed that ABT-199 can fit into active site of ALK<sup>Mutant</sup>.
Published 2025Subjects: